[Erlotinib (Tarceva) induced severe exanthema].
Fernández-Guarino
M
M
Garrido López
P
P
González-García
C
C
Jaén
P
P
D001706:Biopsy; D003875:Drug Eruptions / Q000209:etiology*; D000069347:Erlotinib Hydrochloride; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D013997:Time Factors
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride